Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit is an experimental tool used to measure the concentration of CEACAM5 protein in a sample.
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market is projected to reach US$ 16 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Research Institute are the major drivers for the industry.
CEACAM5 is a membranous cell adhesion molecule, one of the members of the carcinoembryonic antigen family. It plays a role in cell adhesion, signal transduction and intercellular communication, and is especially upregulated in cancer cells, so it is of great significance in the diagnosis and monitoring of cancer. By using the CEACAM5 ELISA kit, specific antibodies can be used to capture the CEACAM5 protein in the sample, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulation of CEACAM5 in cancer occurrence, development, and cancer-related disease mechanisms, providing an important tool for cancer research and clinical diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Elabscience Biotechnology Inc.
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Abcam
Wuhan Fine Biotech Co., Ltd.
ZellBio GmbH
Boster Biological Technology
RayBiotech, Inc.
CUSABIO
Thermo Fisher Scientific (China) Co., Ltd.
Biorbyt
CLOUD-CLONE CORP.
Biomatik
Segment by Type
Human
Mouse
Rat
Others
Hospital
Research Institute
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit introduction, etc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market is projected to reach US$ 16 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Research Institute are the major drivers for the industry.
CEACAM5 is a membranous cell adhesion molecule, one of the members of the carcinoembryonic antigen family. It plays a role in cell adhesion, signal transduction and intercellular communication, and is especially upregulated in cancer cells, so it is of great significance in the diagnosis and monitoring of cancer. By using the CEACAM5 ELISA kit, specific antibodies can be used to capture the CEACAM5 protein in the sample, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulation of CEACAM5 in cancer occurrence, development, and cancer-related disease mechanisms, providing an important tool for cancer research and clinical diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Elabscience Biotechnology Inc.
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Abcam
Wuhan Fine Biotech Co., Ltd.
ZellBio GmbH
Boster Biological Technology
RayBiotech, Inc.
CUSABIO
Thermo Fisher Scientific (China) Co., Ltd.
Biorbyt
CLOUD-CLONE CORP.
Biomatik
Segment by Type
Human
Mouse
Rat
Others
Segment by Application
Hospital
Research Institute
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit introduction, etc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) ELISA Kit market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices